Impact of mifepristone, a glucocorticoid/progesterone antagonist, on HDL cholesterol, HDL particle concentration, and HDL function.
about
Mifepristone reduces insulin resistance in patient volunteers with adrenal incidentalomas that secrete low levels of cortisol: a pilot studyCardiovascular disease risk reduction by raising HDL cholesterol--current therapies and future opportunities.Evaluation of Evidence of Adrenal Insufficiency in Trials of Normocortisolemic Patients Treated With Mifepristone.
P2860
Impact of mifepristone, a glucocorticoid/progesterone antagonist, on HDL cholesterol, HDL particle concentration, and HDL function.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Impact of mifepristone, a gluc ...... ncentration, and HDL function.
@ast
Impact of mifepristone, a gluc ...... ncentration, and HDL function.
@en
type
label
Impact of mifepristone, a gluc ...... ncentration, and HDL function.
@ast
Impact of mifepristone, a gluc ...... ncentration, and HDL function.
@en
prefLabel
Impact of mifepristone, a gluc ...... ncentration, and HDL function.
@ast
Impact of mifepristone, a gluc ...... ncentration, and HDL function.
@en
P2093
P2860
P356
P1476
Impact of mifepristone, a gluc ...... oncentration, and HDL function
@en
P2093
Brian Ishida
Cheryl J Cox
Chongren Tang
Coleman Gross
Jay W Heinecke
Jonathan Q Purnell
Peter M Schaefer
Richard L Weinstein
Ronald M Krauss
P2860
P304
P356
10.1210/JC.2011-2813
P407
P50
P577
2012-03-07T00:00:00Z